Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Censoring Survival Data

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inflammatory Biomarkers and Their Associations with Arrhythmic Burden Following SGLT2-I Treatment in Chronic Heart Failure-A Subanalysis of the ERASe Trial.

Journal of clinical medicine·2026

Same author

A feature selection-based oblique hyperplane for oblique random survival forests.

BMC medical research methodology·2026

Same author

Increased urinary IgM excretion in patients with obstructive sleep apnea.

Respiratory medicine·2026

Same author

Impact of Ertugliflozin on Cardiac Structure and Function in Patients with ICDs/CRT-Ds Assessed by Echocardiography: A Post Hoc Sub-Analysis of the ERASe Trial.

Journal of clinical medicine·2025

Same author

Comparison of oblique random survival forest, random survival forest, and statistical models for time-to-event data using simulation study.

Scientific reports·2025

Same author

Mitigating Night Biomass Loss in Outdoor Pilot-Scale Mixotrophic Algal Cultivation of Monoraphidium minutum Using Flue Gas Condensate and Cheese Whey.

Biotechnology and bioengineering·2025

Search research articles

Related Experiment Video

Updated: Mar 31, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Variable selection in a flexible parametric mixture cure model with interval-censored data.

Sylvie Scolas¹, Anouar El Ghouch¹, Catherine Legrand¹

¹Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA), Université catholique de Louvain, Louvain-la-Neuve, Belgium.

Statistics in Medicine

|October 16, 2015

Summary

This summary is machine-generated.

This study introduces a new statistical model for survival analysis with interval-censored data and a cure fraction, crucial for understanding diseases like Alzheimer's. The method effectively selects important variables, improving predictions for individuals who may never experience the event.

Keywords:

accelerated failure time adaptive LASSO cure model extended generalized gamma interval-censoring

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Related Experiment Videos

Last Updated: Mar 31, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Area of Science:

Biostatistics
Medical Statistics
Survival Analysis

Background:

Standard survival analysis assumes all individuals experience the event, which is not always true.
Medical data often involves interval-censored events (time known only between visits) and a proportion of uncured individuals.
Variable selection is challenging when covariates affect survival differently than the probability of experiencing the event.

Purpose of the Study:

Develop a flexible parametric statistical model for interval-censored data with a cure fraction and many potential covariates.
Address the need for robust variable selection in complex survival data settings.
Improve understanding of factors influencing disease progression and susceptibility.

Main Methods:

Utilized a parametric mixture cure model with an accelerated failure time regression for survival.
Employed the extended generalized gamma distribution for the error term.
Extended the adaptive LASSO method for stable and continuous variable selection in this context.

Main Results:

Simulation studies demonstrated the good performance of the proposed method.
Evaluated the behavior of estimates under varying cure and censoring proportions.
Successfully applied the method to real-world data on mild cognitive impairment conversion.

Conclusions:

The developed statistical model effectively handles interval-censored data with a cure fraction and performs robust variable selection.
The approach offers a valuable tool for analyzing complex medical data, particularly in neurodegenerative disease research.
The method's performance is validated through simulations and a practical application, highlighting its utility.